PGHL

PROCTER & GAMBLE HEALTH

Mid Cap BSE: 500126 NSE: PGHL
₹4375.00
16.5 (0.38%)
As on 12 August, 2022 | 21:23

Procter & Gamble Health Share Price

Procter & Gamble Health Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Procter & Gamble Health Share Returns

  • Over 1 Month 2.19%
  • Over 3 Month 1.64%
  • Over 6 Month -11.18%
  • Over 1 Year -19.46%

Procter & Gamble Health Key Statistics

P/E Ratio 39.2
PEG Ratio -11.5
Market Cap Cr 7,262
Price to Book Ratio 10.3
EPS 106.7
Dividend 3.9
Relative Strength Index 52.89
Money Flow Index 57.79
MACD Signal 46.44
Average True Range 93.77

Procter & Gamble Health Investment Rating

  • Master Rating:
  • Procter & Gamble Health has an operating revenue of Rs. 1,103.91 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of 23% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Health Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 268
  • 278
  • 273
  • 285
  • 219
  • Operating Expenses Qtr Cr
  • 199
  • 216
  • 195
  • 237
  • 188
  • Operating Profit Qtr Cr
  • 69
  • 62
  • 78
  • 48
  • 31
  • Depreciation Qtr Cr
  • 6
  • 7
  • 7
  • 7
  • 8
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 14
  • 15
  • 19
  • 10
  • 10
  • Net Profit Qtr Cr
  • 51
  • 45
  • 55
  • 34
  • 16

Procter & Gamble Health Technicals

EMA & SMA

Current Price
4370.5
12 (0.28%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • 4363.72
  • 50 Day
  • 4318.73
  • 100 Day
  • 4390.97
  • 200 Day
  • 4653.85
  • 20 Day
  • 4371
  • 50 Day
  • 4256.02
  • 100 Day
  • 4284.97
  • 200 Day
  • 4651.62

Procter & Gamble Health Resistance and Support

PIVOT
₹4383.39
Resistance
  • First Resistance
  • 4420.12
  • Second Resistance
  • 4481.74
  • Third Resistance
  • 4518.47
Support
  • First Resistance
  • 4321.77
  • Second Resistance
  • 4285.04
  • Third Resistance
  • 4223.42
  • RSI
  • 52.89
  • MFI
  • 57.79
  • MACD Single Line
  • 46.44
  • MACD
  • 38.47

Procter & Gamble Health Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 2,280
  • 123,097
  • 53.99
  • Week
  • 3,190
  • 185,194
  • 58.05
  • 1 Month
  • 4,960
  • 286,013
  • 57.66
  • 6 Month
  • 15,603
  • 1,050,056
  • 67.3

Procter & Gamble Health Result Highlights

Procter & Gamble Health Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1008.73 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2021. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
  • Market Cap
  • 7,255
  • Sales
  • 1,104
  • Shares in Float
  • 0.80
  • No of funds
  • 112
  • Yield
  • 1.86
  • Book Value
  • 10.32
  • U/D Vol ratio
  • 1.7
  • LTDebt / Equity
  • Alpha
  • -0.09
  • Beta
  • 0.43

Procter & Gamble Health

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 51.82%
  • 51.82%
  • 51.82%
  • Mutual Funds
  • 6.61%
  • 6.44%
  • 7.07%
  • Insurance Companies
  • 1.46%
  • 1.46%
  • 1.46%
  • Foreign Portfolio Investors
  • 6.47%
  • 6.57%
  • 5.97%
  • Financial Institutions/ Banks
  • Individual Investors
  • 25.09%
  • 24.81%
  • 24.56%
  • Others
  • 8.55%
  • 8.9%
  • 9.12%

Procter & Gamble Health Management

  • Name
  • Designation
  • Mr. Suresh Talwar
  • Chairman & Ind.Director
  • Mr. Milind Thatte
  • Managing Director
  • Mr. Amit Gupta
  • Executive Director (Finance) & CFO
  • Mrs. Rani Jadhav
  • Independent Director
  • Mr. Aalok Agrawal
  • Non Executive Director
  • Dr. Elizabeth Desmond
  • Non Executive Director

Procter & Gamble Health Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Health Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-29
  • Audited Results & Final Dividend
  • 2022-05-05
  • Quarterly Results & Interim Dividend
  • 2022-02-09
  • Quarterly Results
  • 2021-11-09
  • Quarterly Results
  • 2021-08-26
  • Audited Results & Final Dividend
  • Date
  • Purpose
  • Remarks
  • 2022-05-13
  • INTERIM
  • Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health MF Shareholding

  • Name
  • Amount(cr)
  • Nippon India Small Cap Fund - Growth
  • 20363
  • HDFC Small Cap Fund Growth
  • 12934
  • UTI Focused Equity Fund Regular Growth
  • 2842
  • UTI MNC Fund Regular Plan Growth
  • 2529
  • Tata Flexi Cap Fund Regular Growth
  • 2161

Procter & Gamble Health FAQs

What is Share Price of Procter & Gamble Health ?

Procter & Gamble Health share price is ₹4375 As on 12 August, 2022 | 21:09

What is the Market Cap of Procter & Gamble Health ?

The Market Cap of Procter & Gamble Health is ₹7262.2 Cr As on 12 August, 2022 | 21:09

What is the P/E ratio of Procter & Gamble Health ?

The P/E ratio of Procter & Gamble Health is 39.2 As on 12 August, 2022 | 21:09

What is the PB ratio of Procter & Gamble Health ?

The PB ratio of Procter & Gamble Health is 10.3 As on 12 August, 2022 | 21:09

Q1FY23